Human lifestyle in Contact With Dogs and Risk of Infection With Protozoan Parasites

2014 ◽  
Vol 1 (4) ◽  
Author(s):  
Mahdi Mosayebi
2016 ◽  
Vol 46 (3) ◽  
pp. 241-246 ◽  
Author(s):  
Raylene Andrade OLIVEIRA ◽  
Rodrigo GURGEL-GONÇALVES ◽  
Eleuza Rodrigues MACHADO

ABSTRACT Approximately 90% of the population in the northwestern Amazonia is composed of indigenous people and their healthcare is still a challenge. The objective of this study was to determine the frequency of parasites in two indigenous ethnic groups (Baré and Baniwa) in northwestern Amazonia. Stool samples from 270 individuals (199 Baniwa and 71 Baré) were analyzed using Richie's method and the spontaneous sedimentation method. Statistical differences among the proportions of infected individuals based on gender, age, and ethnicity were determined. All individuals were infected by protozoans or helminths. The most frequent parasites in the indigenous people were Ascaris lumbricoides (73%), Entamoeba spp. (53%), and Giardia intestinalis (48%). Protozoan parasites were more common among children aged 0-12 years; however, the frequency of helminths, such as hookworms and A. lumbricoides, was higher in adults. There were no significant differences in parasite frequencies between different genders or ethnic groups. Mixed infections by two or more protozoan and/or helminth species were detected in 96% of individuals. One individual was infected by 14 species. A high frequency of intestinal parasites was found in Baré and Baniwa ethnic groups. Improvements to infrastructure and health education programs are required to reduce risk of infection by intestinal parasites.


2016 ◽  
Vol 04 (01) ◽  
pp. 4-10

AbstractImmunosuppression permits graft survival after transplantation and consequently a longer and better life. On the other hand, it increases the risk of infection, for instance with cytomegalovirus (CMV). However, the various available immunosuppressive therapies differ in this regard. One of the first clinical trials using de novo everolimus after kidney transplantation [1] already revealed a considerably lower incidence of CMV infection in the everolimus arms than in the mycophenolate mofetil (MMF) arm. This result was repeatedly confirmed in later studies [2–4]. Everolimus is now considered a substance with antiviral properties. This article is based on the expert meeting “Posttransplant CMV infection and the role of immunosuppression”. The expert panel called for a paradigm shift: In a CMV prevention strategy the targeted selection of the immunosuppressive therapy is also a key element. For patients with elevated risk of CMV, mTOR inhibitor-based immunosuppression is advantageous as it is associated with a significantly lower incidence of CMV events.


Sign in / Sign up

Export Citation Format

Share Document